Last reviewed · How we verify

Epikeia coatings with lidocaine

Biomedical Development Corporation · Phase 1 active Small molecule

Epikeia coatings with lidocaine is a Small molecule drug developed by Biomedical Development Corporation. It is currently in Phase 1 development. Also known as: Epikeia coatings with local anesthetic.

At a glance

Generic nameEpikeia coatings with lidocaine
Also known asEpikeia coatings with local anesthetic
SponsorBiomedical Development Corporation
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Epikeia coatings with lidocaine

What is Epikeia coatings with lidocaine?

Epikeia coatings with lidocaine is a Small molecule drug developed by Biomedical Development Corporation.

Who makes Epikeia coatings with lidocaine?

Epikeia coatings with lidocaine is developed by Biomedical Development Corporation (see full Biomedical Development Corporation pipeline at /company/biomedical-development-corporation).

Is Epikeia coatings with lidocaine also known as anything else?

Epikeia coatings with lidocaine is also known as Epikeia coatings with local anesthetic.

What development phase is Epikeia coatings with lidocaine in?

Epikeia coatings with lidocaine is in Phase 1.

Related